ATC II INC /DE/
10QSB/A, 1996-08-30
MOTION PICTURE & VIDEO TAPE DISTRIBUTION
Previous: PUTNAM NEW OPPORTUNITIES FUND, N-30D, 1996-08-30
Next: ATC II INC /DE/, 10QSB/A, 1996-08-30



                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549



                                 FORM 10-QSB/A-1



(Mark One)


[X]  Quarterly  report  under  Section  13 or 15(d) of the  Securities
Exchange Act of 1934 for the quarterly period ended September 30, 1995

[ ]  Transition  report  under  Section 13 or 15(d) of the  Securities
Exchange  Act  of  1934  (No  fee  required)  for  the  transition  period  from
____________________ to _____________________



Commission file number:  0-19069



                                  ATC II, INC.
                 (Name of Small Business Issuer in Its Charter)



             Delaware                                           75-2395356
(State or Other Jurisdiction of                               (I.R.S. Employer
Incorporation or Organization)                              Identification No.)




                 6701 Baum Drive, Suite 345, Knoxville, TN 37919
               (Address of Principal Executive Offices) (Zip Code)


                                 (423) 588-1018
                (Issuer's Telephone Number, Including Area Code)




Check whether the issuer:  (1) filed all reports required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days.


                                    Yes __  No XX



     The number of shares  outstanding  of the issuer's  common stock ($0.01 par
value), as of July 8, 1996 was 4,996,811.

     Total  of  sequentially  numbered  pages:  7  Exhibit  Index on Page [7] to
release the Company  from any and all actual or  potential  claims they may have
had  against  the  Company  stemming  from  their  respective  ownership  of the
Preferred Stock, including accrued dividends.
<PAGE>
ITEM 5.           OTHER INFORMATION



         On January 19,  1996,  James L.  Thompson  resigned as president of the
Company.  Mr.  Thompson was initially  appointed as president  because he helped
introduce the Company to Turner,  Turner & Associates ("TTA") and negotiated the
Purchase  Agreement  with TTA. As a finders fee, Mr.  Thompson,  along with Jack
Hartgrove,  received a quantity  of shares of the  Company's  common  stock that
constitued a controlling  interest in the Company.  When the Purchase  Agreement
was rescinded, all shares issued to Mr. Thompson and Mr. Hartgrove were canceled
by the Company. Mr. Thompson's resignation was a result of the rescission of the
Purchase  Agreement,  and did not reflect any disagreements with the Company. He
remained with the Company in the capacity of director.

         Upon the resignation of Mr. Thompson,  the Company appointed Richard H.
Turner as  president  and a director.  Mr.  Turner was the  president of TTA and
helped  develop the patents that the Company was attempting to acquire from TTA.
Mr. Turner was appointed to help facilitate negotiations between the Company and
TTA, and because of his familiarity with the patents that the Company was trying
to acquire. No agreement was ever reached between TTA and the Company,  however,
and the parties have since terminated all  negotiations in furtherance  thereof.
Accordingly,  Richard  Turner  resigned as the Company's  president and director
effective May 6, 1996.

         On August 20, 1996,  the Company  appointed  Dr.  Gerald  Curtis as its
president and director.  The Form 10-QSB for fiscal quarter ended  September 30,
1995  initially  filed by the  Company on July 29,  1996  indicated  that Leslie
Carter had been  appointed as the  president  and director of the Company.  This
discrepency was based on a miscommunication between the Company, Jack Hartgrove,
James Thompson,  Leslie Carter and the Company's filing agent,  Canton Financial
Services  Corporation,  concerning the Company's  relationship  with Ms. Carter.
Leslie Carter has never been appointed as an officer or director of the Company.
Jack  Hartgove  and James  Thompson  resigned as officers  and  directors of the
Company immediately after this situation was resolved, leaving Dr.
Curtis as the Company's sole officer and director.

         In January 1996, the Company relocated its corporate  headquarters from
6701  Baum  Drive,  Suite  345,  Knoxville,  Tennessee,  37919  to  1001 A South
Interstate 45, Post Office Box 729, Hutchins, Texas 75141-0729. In May 1996, the
Company moved its  headquarters  back to 6701 Baum Drive,  Suite 345,  Knoxville
Tennessee,  37919.  Corporate  offices were returned to Tennessee as a result of
the termination of negotiations between TTA and the Company.



ITEM 6.           EXHIBITS AND REPORTS ON FORM 8-K



(a)      Index to  Exhibits.  Exhibits  required  to be  attached by Item 601 of
         Regulation  S-B are listed in the Index to Exhibits  beginning on
         page 7 of this  Form  10-QSB,  which is  herein  incorporated  by
         reference.

(b)      Reports on Form 8-K. On September  26, 1995,  the Company  filed a Form
         8-K to  report  its  acquisition  of  patents  from  Turner,  Turner  &
         Associates pursuant to a June 30, 1995 Purchase Agreement (the Purchase
         Agreement was later rescinded).  No financial  statements were required
         to be filed with that report since the Company acquired assets only and
         not an ongoing business.
<PAGE>



                                   SIGNATURES

         In  accordance  with  Section  13 or 15(d)  of the  Exchange  Act,  the
registrant  caused  this  report to be signed on its behalf by the  undersigned,
thereunto duly authorized, this 30th day of August 1996.

         ATC II, INC.


         /s/ Dr. Gerald Curtis
         Dr. Gerald Curtis

         In accordance  with the Exchange Act, this report has been signed below
by the following  persons on behalf of the  registrant and in the capacities and
on the dates indicated.

Signature                       Title                            Date



/s/ Dr. Gerald Curtis           President and Director           August 30, 1996
- ------------------------------
Dr. Gerald Curtis


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission